2013-: Associate professor, Experimental Pharmacology, Dept. of Veterinary Disease Biology

2007-2013 : Assistant professor, Section of Pharmacology and Toxicology, Dept. of Veterinary Disease Biology

2003-2006: PhD student, Section of Anatomy and Biochemistry / Dept. of Basic Animal and Veterinary Science

2002-2003: Teaching assistant at the Large Animal Surgery, KVL

2000-2002: Veterinary practitioner

Academic Degrees

2022: Doctor of Medical Sciences "A role of vitamin C in the young brain - effects of deficiency in a  model of human hypovitaminosis C"

2006: PhD in Cell biology "Pre- and peri-implantation development in ruminants - some morphological and epigenetic aspects"

2000: Doctor of veterinary medicine

Preclinical animal models and their translational potential

The development of NAFLD, NASH and hepatic fibrosis, and the evaluation of putative interventions

The influence of vitamin C on the developing brain and brain function

The guinea pig as a model of NAFLD/NASH

The effect of diet-induced and pharmacological interventions on the devlopment and resolution of NAFLD/NASH

Ex vivo culture of liver slices ("The liver in a dish") as preclincial tool in NAFLD/NASH research

Effects of vitamin C deficiency in vivo (depletion/repletion)

Biomedicine

In vivo pharmacology

Veterinary Pharmacology

I have been employed at the Dept. of Veterinary and Animal Sciences since April 2007. from 2013 as Assoc. Prof. in Experimental Pharmacology. My main area of competence is preclinical animal models and their translational potential, with a current emphasis on fatty liver disease (NAFLD), its progression to NASH and hepatic fibrosis, and putative therapeutic modalities. I also have a keen research interest concerning the potential effects of dietary vitamin C particularly in the brain during development. In addition, I collaborate on individual research projects concerning other types of preclinical models of human disease and the assessment of pharmacological and toxicologial effects in vivo, and - to some degree-  effects ex vivo and in vitro. 

Pernille Tveden-Nyborg has present or former collaborations - of which some include funding - with  the Lifepharm center, Novo Nordisk, Nordic Bioscience and Chr. Hansen.

Pernille Tveden-Nyborg functions as associate editor of the scientific journals  'Basic and Clinical Pharmacology and Toxicology' and 'ACTA Vet Scandinavica'.